These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31807856)

  • 41. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives.
    Maixent JM; Pons O; Sennoune SR; Sadrin S
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):211-214. PubMed ID: 32538776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial.
    Shulman RJ; Hollister EB; Cain K; Czyzewski DI; Self MM; Weidler EM; Devaraj S; Luna RA; Versalovic J; Heitkemper M
    Clin Gastroenterol Hepatol; 2017 May; 15(5):712-719.e4. PubMed ID: 27080737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome].
    Tsukanov VV; Rzhavicheva OS; Vasjutin AV; Dunaevskaja OV; Tonkih JL; Bronnikova EP
    Ter Arkh; 2016; 88(8):40-45. PubMed ID: 27636926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dry jelly concentrate with vitamins and dietary fiber in patients with IBS with constipation: a comparative controlled study].
    Pilipenko VI; Teplyuk DA; Shakhovskaya AK; Isakov VA; Vorobyova VM; Vorobyova IS; Glazkova IV; Kochetkova AA; Mikheeva GA; Yudina AV
    Vopr Pitan; 2015; 84(6):83-91. PubMed ID: 29378102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics.
    Drisko J; Bischoff B; Hall M; McCallum R
    J Am Coll Nutr; 2006 Dec; 25(6):514-22. PubMed ID: 17229899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial.
    Abbas Z; Yakoob J; Jafri W; Ahmad Z; Azam Z; Usman MW; Shamim S; Islam M
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):630-9. PubMed ID: 24722560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
    Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
    J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
    Patel A; Hasak S; Cassell B; Ciorba MA; Vivio EE; Kumar M; Gyawali CP; Sayuk GS
    Aliment Pharmacol Ther; 2016 Aug; 44(3):246-58. PubMed ID: 27240555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
    Qi Q; Zhang Y; Chen F; Zuo X; Li Y
    BMC Gastroenterol; 2018 Jan; 18(1):5. PubMed ID: 29310568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study.
    Coban Ş; Akbal E; Köklü S; Köklü G; Ulaşlı MA; Erkeç S; Aktaş B; Yüksel O; Koçak E; Erdem HR
    Digestion; 2012; 86(2):86-93. PubMed ID: 22846190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.
    Drossman DA; Morris C; Hu Y; Leserman J; Dalton C; Toner B; Diamante N; Bangdiwala S
    J Clin Gastroenterol; 2008; 42(10):1080-8. PubMed ID: 18949838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.
    Hod K; Sperber AD; Ron Y; Boaz M; Dickman R; Berliner S; Halpern Z; Maharshak N; Dekel R
    Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28271623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
    Black CJ; Burr NE; Camilleri M; Earnest DL; Quigley EM; Moayyedi P; Houghton LA; Ford AC
    Gut; 2020 Jan; 69(1):74-82. PubMed ID: 30996042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.